Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

The Center in Asbury Park wants people to "Come Early, Stand Proud, and Walk Strong" on May 4 for the New Jersey AIDS Walk ...

A man was charged with mother after his wife allegedly died from AIDS that she contracted from him after he never told her he ...

The Trump Administration has gutted many areas of healthcare funding and research, especially in infectious diseases. One ...

“Trump ’47 should not allow Trump ’45’s massive public health achievement to be cancelled — especially when that legacy will ...

Young people still face high HIV risks despite PrEP Learn why prevention efforts must center Gen Z for a healthier future.

Serhat Gumrukcu, 42, hired Jerry Banks through two associates to murder Gregory Davis in 2018, in Vermont, U.S. Attorney's ...

A modeling study looked at how anticipated cuts to international HIV funding would affect the rate of new cases and ...

A new report shows a sharp rise in STIs in Houston and Harris County, with the city's rates now exceeding statewide averages ...

Despite steep budget and staffing cuts at the FDA in recent weeks and other headwinds, Gilead CEO Daniel O’Day assured investors that the pharma’s plans and preparations for lenacapavir’s launch ...

Roper St. Francis Health Services Center hosted a "Dining Out for Life" fundraiser Thursday, aiming to raise money for ...